A carregar...

Rituximab for Refractory Rheumatoid Arthritis: A 24-Week Open-Label Prospective Study

OBJECTIVES: To study the efficacy of rituximab in active rheumatoid arthritis (RA) patients refractory to disease modifying anti-rheumatic drugs (DMARDs) including the tumor necrosis factor (TNF)-α antagonists. METHODS: Adult patients with active RA despite adequate therapies with conventional DMARD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ho, Ling Yin, Mok, Chi Chiu, To, Chi Hung, Mak, Anselm, Cheung, Mei Yuk, Yu, Ka Lung
Formato: Artigo
Idioma:Inglês
Publicado em: Bentham Science Publishers Ltd. 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2581826/
https://ncbi.nlm.nih.gov/pubmed/19088893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874312900701010001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!